We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Evaluation of Foot-and-Mouth Disease (FMD) Virus Asia1 Genotype-V as an FMD Vaccine Candidate: Study on Vaccine Antigen Production Yield and Inactivation Kinetics.
- Authors
Kim, Jae Young; Park, Sun Young; Park, Sang Hyun; Lee, Gyeongmin; Jin, Jong-Sook; Kim, Dohyun; Park, Jong-Hyeon; Jeong, Seong-Yun; Ko, Young-Joon
- Abstract
South Korea has experienced outbreaks of foot-and-mouth disease (FMD) of serotypes O and A, leading to nationwide vaccination with a bivalent vaccine. Since the FMD virus (FMDV) Asia1 group-V genotype occurred in North Korea in 2007, an Asia1/MOG/05 vaccine strain belonging to the Asia1 group-V genotype was developed using a genetic recombination method (Asia1/MOG/05-R). This study aimed to evaluate the antigen productivity and viral inactivation kinetics of Asia1/MOG/05-R to assess its commercial viability. The antigen yield of Asia1/MOG/05-R produced in flasks and bioreactors was approximately 4.0 μg/mL. Binary ethylenimine (BEI) inactivation kinetics of Asia1/MOG/05-R showed that 2 mM and 1.0 mM BEI treatment at 26 °C and 37 °C, respectively, resulted in a virus titer <10−7 TCID50/mL within 24 h, meeting the inactivation kinetics criteria. During incubation at 26 °C and 37 °C, 10% antigen loss occurred, but not due to BEI treatment. When pigs were inoculated twice with the Asia1/MOG/05-R antigen, the virus neutralization titer increased to approximately 1:1000; therefore, it can sufficiently protect against Asia1/MOG/05-R and Asia1 Shamir viruses. The Asia1/MOG/05-R will be useful as a vaccine strain for domestic antigen banks.
- Subjects
NORTH Korea; SOUTH Korea; FOOT &; mouth disease; ANTIGENS; GENETIC recombination; VIRAL antigens; VACCINES
- Publication
Vaccines, 2024, Vol 12, Issue 2, p185
- ISSN
2076-393X
- Publication type
Article
- DOI
10.3390/vaccines12020185